Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term glycemic control with rimonabant in treatment-naïve type 2 diabetes
2004-004881-34Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Rimonabant 20 mg with Placebo (2 arms). Primary endpoint: Change in HbA1c from baseline to Month 6. Started Feb 2005; status: completed.
02
Drugs
rimonabant
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2004-004881-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004881-34.